Literature DB >> 9292016

Molecular analysis of dengue virus attenuation after serial passage in primary dog kidney cells.

B Puri1, W M Nelson, E A Henchal, C H Hoke, K H Eckels, D R Dubois, K R Porter, C G Hayes.   

Abstract

The complete nucleotide sequences of the genomes of dengue-1 virus virulent 45AZ5 PDK-O and attenuated vaccine candidate strain 45AZ5 PDK-27 have been determined and compared with the dengue-1 virus Western Pacific (West Pac) 74 parent strain from which 45AZ5 PDK-O was derived. Twenty-five (0.23%) nucleotide and 10 (0.29%) amino acid substitutions occurred between parent strain dengue-1 virus West Pac 74 and virulent strain 45AZ5 PDK-O, which was derived from the parent by serial passage in diploid foetal rhesus lung (FRhL-2) and mutagenized with 5-azacytidine. These substitutions were preserved in the 45AZ5 PDK-27 vaccine. 45AZ5 PDK-O and PDK-27 strains, which differ by 27 passages in primary dog kidney (PDK) cells, show 25 (0.23%) nucleotide and 11 (0.32%) amino acid divergences. These comparative studies suggest that the changes which occurred between the West Pac 74 and 45AZ5 PDK-O strains may alter the biological properties of the virus but may not be important for attenuation. Important nucleotide base changes responsible for attenuation accumulated between 45AZ5 PDK-O and 27.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9292016     DOI: 10.1099/0022-1317-78-9-2287

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  15 in total

1.  Construction of a full length infectious clone for dengue-1 virus Western Pacific,74 strain.

Authors:  B Puri; S Polo; C G Hayes; B Falgout
Journal:  Virus Genes       Date:  2000       Impact factor: 2.332

2.  Attenuation markers of a candidate dengue type 2 vaccine virus, strain 16681 (PDK-53), are defined by mutations in the 5' noncoding region and nonstructural proteins 1 and 3.

Authors:  S Butrapet; C Y Huang; D J Pierro; N Bhamarapravati; D J Gubler; R M Kinney
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

3.  Chimeric dengue type 2 (vaccine strain PDK-53)/dengue type 1 virus as a potential candidate dengue type 1 virus vaccine.

Authors:  C Y Huang; S Butrapet; D J Pierro; G J Chang; A R Hunt; N Bhamarapravati; D J Gubler; R M Kinney
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

4.  Complete nucleotide sequence analysis of a Western Pacific dengue-1 virus strain.

Authors:  B Puri; W Nelson; K R Porter; E A Henchal; C G Hayes
Journal:  Virus Genes       Date:  1998       Impact factor: 2.332

5.  Chemical mutagenesis of dengue virus type 4 yields mutant viruses which are temperature sensitive in vero cells or human liver cells and attenuated in mice.

Authors:  J E Blaney; D H Johnson; C Y Firestone; C T Hanson; B R Murphy; S S Whitehead
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

6.  Genetic determinants responsible for acquisition of dengue type 2 virus mouse neurovirulence.

Authors:  M Bray; R Men; I Tokimatsu; C J Lai
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

7.  Yellow fever virus/dengue-2 virus and yellow fever virus/dengue-4 virus chimeras: biological characterization, immunogenicity, and protection against dengue encephalitis in the mouse model.

Authors:  Thomas J Chambers; Yan Liang; Deborah A Droll; Jacob J Schlesinger; Andrew D Davidson; Peter J Wright; Xiaoshan Jiang
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

8.  Live attenuated tetravalent dengue virus host range vaccine is immunogenic in African green monkeys following a single vaccination.

Authors:  Caitlin M Briggs; Katherine M Smith; Amanda Piper; Emerson Huitt; Carla J Spears; Michelle Quiles; Mariana Ribeiro; Malcolm E Thomas; Dennis T Brown; Raquel Hernandez
Journal:  J Virol       Date:  2014-04-02       Impact factor: 5.103

9.  A live, attenuated dengue virus type 1 vaccine candidate with a 30-nucleotide deletion in the 3' untranslated region is highly attenuated and immunogenic in monkeys.

Authors:  Stephen S Whitehead; Barry Falgout; Kathryn A Hanley; Joseph E Blaney; Lewis Markoff; Brian R Murphy
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

10.  Complete genome analysis of a frog virus 3 (FV3) isolate and sequence comparison with isolates of differing levels of virulence.

Authors:  Elizabeth A Morrison; Shawn Garner; Pierre Echaubard; David Lesbarrères; Christopher J Kyle; Craig R Brunetti
Journal:  Virol J       Date:  2014-03-12       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.